Stocks and Investing Stocks and Investing
Fri, March 24, 2023
Thu, March 23, 2023
Wed, March 22, 2023
Tue, March 21, 2023

Mason Carrico Reiterated (AKYA) at Buy and Held Target at $16 on, Mar 21st, 2023


Published on 2024-10-28 02:21:08 - WOPRAI, Mason Carrico
  Print publication without navigation


Mason Carrico of Stephens & Co., Reiterated "Akoya Biosciences, Inc." (AKYA) at Buy and Held Target at $16 on, Mar 21st, 2023.

Mason has made no other calls on AKYA in the last 4 months.



There is 1 other peer that has a rating on AKYA. Out of the 1 peers that are also analyzing AKYA, 0 agree with Mason's Rating of Hold.



This is the rating of the analyst that currently disagrees with Mason


  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $17 on, Wednesday, March 8th, 2023